Role of leukotrienes in antimicrobial defense of the lung

Journal of Laboratory and Clinical Medicine

Volumn 132, Issue 4, 1998, Pages 251-257

  Peters Golden, Marc ^a,b   Coffey, Michael ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0032192089     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(98)90037-3     Document Type: Review

References (42)

1. Standiford T. Cytokines and pulmonary host defenses. Curr Opin Pulm Med 1997;3:81-8.
2. Lohmann-Matthes M, Steinmuller C, Franke-Ullmann G. Pulmonary macrophages. Eur Respir J 1994;7:1678-89.
3. Toews G, Gross G, Pierce A. The relationship of inoculum size to lung bacterial clearance and phagocytic cell response in mice. Am Rev Respir Dis 1980;120:559-66.
4. Ford-Hutchinson A, Gresser M, Young R. 5-Lipoxygenase. Annu Rev Biochem 1994;63:383-417.
5. Claesson H, Lindgren J, Gustafsson B. Opsonized bacteria stimulate leukotriene synthesis in human leukocytes. Biochim Biophys Acta 1985;836:361-7.
6. O'Byrne P, Israel E, Drazen J. Antileukotrienes in the treatment of asthma. Ann Intern Med 1997;127:472-80.
7. Stephenson A, Lonigro A, Hyers T, Webster R, Fowler A. Increased concentrations of leukotrienes in bronchoalveolar lavage fluid of patients with ARDS or at risk of ARDS. Am Rev Respir Dis 1988;138:714-9.
8. Wilborn J, Bailie M, Coffey M, Burdick M, Stricter R, Peters-Golden M. Constitutive activation of 5-lipoxygenase in the lungs of patients with idiopathic pulmonary fibrosis. J Clin Invest 1996;97:1827-36.
9. Hopkins H, Stull T, Von Essen S, Robbins R, Rennard S. Neutrophil chemotactic factors in bacterial pneumonia. Chest 1989;95:1021-7.
10. Buret A, Dunkley M, Clancy R, Cripps A. Effector mechanisms of intestinally induced immunity to Pseudomonas aeruginosa in the rat lung: role of neutrophils and leukotriene B4. Infect Immun 1993;61:671-9.
11. Bailie M, Standiford T, Laichalk L, Coffey M, Strieter R, Peters-Golden M. Leukotriene-deficient mice manifest enhanced lethality from Klebsiella pneumonia in association with decreased alveolar macrophage phagocytic and bactericidal activities. J Immunol 1996;157:5221-4.
12. Bigby TD, Holtzman MJ. Enhanced 5-lipoxygenase activity in lung macrophages compared to monocytes from normal subjects. J Immunol 1987;138:1546-50.
13. Peters-Golden M, McNish RW, Hyzy R, Shelly C, Toews GB. Alterations in the pattern of arachidonate metabolism accompany rat macrophage differentiation in the lung. J Immunol 1990;144:263-70.
14. Grimminger F, Sibelius U, Seeger W. Amplification of LTB4 generation in AM-PMN cocultures: transcellular 5-lipoxygenase metabolism. Am J Physiol (Lung Cell Mol Physiol) 1991;261:L195-203.
15. Chen X, Sheller J, Johnson E, Funk C. Role of leukotrienes revealed by targeted disruption of the 5-lipoxygenase gene. Nature 1994;372:179-82.
16. Coffey M, Phare S, Kazanjian P, Peters-Golden M. 5-Lipoxygenase metabolism in alveolar macrophages from subjects infected with the human immunodeficiency virus. J Immunol 1996;157:393-9.
17. Coffey M, Phare S, George S, Peters-Golden M, Kazanjian P. Granulocyte colony-stimulating factor administration to HIV-infected subjects augments reduced leukotriene synthesis and anticryptococcal activity in neutrophils. J Clin Invest. In Press.
18. Hirschtick R, Glassroth J, Jordan M, Wilcosky T, Wallace J, Kvale P, et al. Bacterial pneumonia in persons infected with the human immunodeficiency virus. N Engl J Med 1995;333:845-51.
19. Limper A, Offord K, Smith T, Martin WI. Pneumocystis carinii pneumonia: differences in lung parasite number and inflammation in patients with and without AIDS. Am Rev Respir Dis 1989;140:1204-9.
20. 4 in bronchoalveolar lavage fluid from HIV-infected patients with bacterial pneumonia. Respir Med 1997:91:317-21.
21. Jubiz W, Draper R, Gale J, Nolan G. Decreased leukotriene B4 synthesis by polymorphonuclear leukocytes from male patients with diabetes mellitus. Prostaglandins Leukot Med 1984:14:305-11.
22. Greco N, Milks M, Panganamala R. Metabolism of arachidonic acid in neutrophils from alloxan-diabetic rabbits. Prostaglandins Leukot Essent Fatty Acids 1990;42:201-8.
23. Laviolette M, Coulombe R, Picard S, Braquet P, Borgeat P. Decreased leukotriene B4 synthesis in smokers' alveolar macrophages in vitro. J Clin Invest 1986;77:54-60.
24. Balter M, Toews G, Peters-Golden M. Multiple defects in arachidonate metabolism in alveolar macrophages from young asymptomatic smokers. J Lab Clin Med 1989;114:662-73.
25. Lu M-C, Peters-Golden M, Hostetler D, Robinson N, Derksen F. Age-related enhancement of 5-lipoxygenase metabolic capacity in cattle alveolar macrophages. Am J Physiol (Lung Cell Mol Physiol 15) 1996;271:L547-54.
26. Skerrett S, Henderson W, Martin T. Alveolar macrophage function in rats with severe protein calorie malnutrition: arachidonic acid metabolism, cytokine release, and antimicrobial activity. J Immunol 1990:144:1052-61.
27. Mauss S, Steinmetz H, Willers R, Manegold C, Kochanek M, Haussinger D, et al. Induction of granulocyte colonystimulating factor by acute febrile infection but not by neutropenia in HIV-seropositive individuals. J AIDS Human Retrovirol 1997;14:430-4.
28. Watari K, Asamo S, Shirafuji N, Kodo H, Ozawa K, Takaku F, et al. Serum granulocyte colony-stimulating factor levels in healthy volunteers and patients with various disorders as estimated by enzyme immunoassay. Blood 1989;73:117-22.
29. Nelson S, Farkas S, Fotheringham N, Ho H, Martie T, Movahhed H. Filgastrim in the treatment of hospitalized patients with community acquired pneumonia. Am J Respir Crit Care Med 1996;1535:A535.
30. 4. Int J Immunopharmacol 1989;11:801-8.
31. Mancuso P, Marshall T, Standiford T, Peters-Golden M. Modulation of rat alveolar macrophage phagocytosis of Klebsiella pneumoniae by 5-lipoxygenase products [abstract]. Am J Respir Crit Care Med. In press.
32. 4 is a complete secretagogue in human neutrophils: a kinetic analysis. Biochem Biophys Res Commun 1982;107:1006-12.
33. 4. J Immunol 1990;144:1909-13.
34. Wijkander J, O'Flaherty J, Nixon A, Wykle R. 5-lipoxygenase products modulate the activity of the 85-kDa phospholipase A2 in human neutrophils. J Biol Chem 1995;270:26543-9.
35. 4 in the human lung: recruitment of neutrophils into the alveolar spaces without a change in protein permeability. J Clin Invest 1989;89:1009-19.
36. 4 receptor antagonist. Biochem Pharmocol 1995;49:1683-90.
37. Strieter R, Kasahara K, Allen R, Standiford T, Rolfe M, Becker F, et al. Cytokine-induced neutrophil-derived interleukin-8. Am J Pathol 1992;141:397-407.
38. Hebert M-J, Takano T, Holthofer H, Brady H. Sequential morphologic events during apoptosis of human neutrophils. Modulation by lipoxygenase-derived eicosanoids. J Immunol 1996;157:3105-15.
39. Rhodes J, Salmon J, Wood J. Macrophage Fcγ2b receptor expression and receptor-mediated phospholipase activity: regulation by endogenous eicosanoids. Eur J Immunol 1985;15:222-7.
40. Peppelenbosch M, Tertoolen L, Hage W, de Laat S. Epidermal growth factor-induced actin remodeling is regulated by 5-lipoxygenase and cyclooxygenase products. Cell 1993;74:565-75.
41. Hubbard N, Erickson K. Role of 5′-lipoxygenase metabolites in the activation of peritoneal macrophages for tumoricidal function. Mol Immunol 1995;160:115-22.
42. Sampson S, Costello J, Sampson A. The effect of inhaled leukotriene B4 in normal and in asthmatic subjects. Am J Respir Crit Care Med 1997;155:1789-92.